In laboratory research, MT2 functions as a non-selective agonist at several melanocortin receptors, providing a controlled tool for investigating melanogenesis, neuroendocrine signaling, and metabolic regulation in preclinical models
If your package arrives with damage, please email us
Injection-Related Risks With Injectable GHK-Cu FDA identifies compounded injectable drugs containing GHK-Cu as a potential immunogenicity risk because of aggregation and peptide-related impurities, and FDA notes limited human data to inform safety considerations [8]
While some manufacturer guidance suggests 30 days, many UK prescribers use a 7-day protocol
The metabolic activation from glucagon receptor stimulation may increase evening alertness in some individuals
Article Summary There is growing interest in GHK-Cu as a skincare and haircare ingredient